renin-angiotensin system

(redirected from Renin-angiotensin)
Also found in: Encyclopedia.

re·nin-an·gi·o·ten·sin sys·tem

a selective regulator of the aldosterone biosynthetic pathway that acts by increasing aldosterone production and sodium retention as a result of volume depletion, with resulting increased renin production in the kidney and conversion of angiotensin I in the plasma to angiotensin II.

re·nin-an·gi·o·ten·sin sys·tem

(RAS) (rē'nin-an-jē-ō-tensin sistĕm)
Selective regulator of the aldosterone biosynthetic pathway that acts by increasing aldosterone production and sodium retention due to volume depletion.
References in periodicals archive ?
Sacubitril/valsartan, which combines the neprilysin inhibitor sacubitril and the angiotensin receptor blocker valsartan, simultaneously inhibits the renin-angiotensin system and augments endogenous vasoactive peptide systems.
New York, NY, August 05, 2019 --(PR.com)-- Quantum Genomics are the creators of Firibastat, a first-in-class brain aminopeptidase inhibitor (BAPAI) that could potentially treat treatment-resistant hypertension by acting in the brain to interfere with the renin-angiotensin system.
Based on drug class the global cardiovascular drugs market is segmented into renin-angiotensin system blockers, beta blockers, diuretics, anti-clotting agents (anti-coagulants and platelet aggregation inhibitors), antihyperlipidemics, other antihypertensive, calcium channel blockers and others.
The renin-angiotensin aldosterone system: Patho-physiological role and pharmacologic inhibition.
TXA302 is a proprietary analogue of the naturally occurring peptide angiotensin, which is part of an alternative pathway of the renin-angiotensin system.
According to the company, TXA302 is a proprietary analogue of the naturally occurring peptide Angiotensin (1-7), which is part of an alternative pathway of the renin-angiotensin system, used in the treatment of stroke.
Blockade of the renin-angiotensin system (RAS) [5] by either an angiotensin-converting enzyme inhibitor (ACE-I), an angiotensin II type 1 receptor (AT1R) blocker (ARB), or the combined inhibition of the angiotensin receptor and neprilysin (ARNI) is a cornerstone in the treatment of patients with heart failure with reduced ejection fraction (HFrEF) (1, 2).
The renin-angiotensin system (RAS) is a highly conserved system that plays a key role in the regulation of blood pressure during osmotic and volume challenges in most vertebrates.
Analyses of gene ontology and pathway enrichment also reveal differential expression of renin-angiotensin system genes in the KEGG pathway in the left atrial myocardium of MR pigs [7].
The renin-angiotensin aldosterone system: Pathophysiological role and pharmacologic inhibition.
"For the past century, the renin-angiotensin system (RAS) has been recognized as one of the major blood pressure regulating systems.